Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat

Neurourology and Urodynamics

Volumn 31, Issue 1, 2012, Pages 148-155

  Aizawa, Naoki ^a   Wyndaele, Jean Jacques ^b   Homma, Yukio ^a   Igawa, Yasuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

afferent nerves; desensitization; rats; transient receptor potential (TRP); urinary bladder

Indexed keywords

CAPSAICIN; GSK 1016790A; PURINERGIC P2X RECEPTOR ANTAGONIST; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RN 1734; TNP ATP; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR AGONIST; VANILLOID RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BLADDER CAPACITY; BLADDER DISTENSION; BLADDER FUNCTION; CYSTOMETRY; DRUG EFFECT; ELECTROSTIMULATION; ENZYME ACTIVATION; FEMALE; MECHANORECEPTOR; MICTURITION; NERVE FIBER; NONHUMAN; PELVIC NERVE; RAT; SINGLE AFFERENT FIBER; URODYNAMICS;

ANIMALS; CAPSAICIN; ELECTRIC STIMULATION; FEMALE; LEUCINE; MODELS, ANIMAL; NERVE FIBERS, UNMYELINATED; NEURONS, AFFERENT; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; TRPV CATION CHANNELS; URINARY BLADDER; URINATION;

EID: 84856223850     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21212     Document Type: Article

References (32)

1. Wu LJ, Sweet TB, Clapham DE,. International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev 2010; 62: 381-404.
2. Nilius B, Droogmans G, Wondergem R,. Transient receptor potential channels in endothelium: Solving the calcium entry puzzle? Endothelium 2003; 10: 5-15.
3. Kohler R, Heyken WT, Heinau P, et al. Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Arterioscler Thromb Vasc Biol 2006; 26: 1495-502.
4. Stein RJ, Santos S, Nagatomi J, et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 2004; 172: 1175-8.
5. Caprodossi S, Lucciarini R, Amantini C, et al. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: Correlation with the pathologic stage. Eur Urol 2008; 54: 612-20.
6. Yu W, Hill WG, Apodaca G, et al. Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium. Am J Physiol Renal Physiol 2011; 300: F49-F59.
7. Birder L, Kullmann FA, Lee H, et al. Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat. J Pharmacol Exp Ther 2007; 323: 227-35.
8. Gevaert T, Vriens J, Segal A, et al. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 2007; 117: 3453-62.
9. Yamada T, Ugawa S, Ueda T, et al. Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder. J Histochem Cytochem 2009; 57: 277-87.
10. Kullmann FA, Shah MA, Birder LA, et al. Functional TRP and ASIC-like channels in cultured urothelial cells from the rat. Am J Physiol Renal Physiol 2009; 296: F892-F901.
11. Avelino A, Cruz F,. TRPV1 (vanilloid receptor) in the urinary tract: Expression, function and clinical applications. Naunyn Schmiedebergs Arch Pharmacol 2006; 373: 287-99.
12. Liedtke W, Choe Y, Marti-Renom MA, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000; 103: 525-35.
13. Strotmann R, Schultz G, Plant TD,. Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site. J Biol Chem 2003; 278: 26541-9.
14. Rosenbaum T, Gordon-Shaag A, Munari M, et al. Ca2+/calmodulin modulates TRPV1 activation by capsaicin. J Gen Physiol 2004; 123: 53-62.
15. Lishko PV, Procko E, Jin X, et al. The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. Neuron 2007; 54: 905-18.
16. Jin M, Wu Z, Chen L, et al. Determinants of TRPV4 activity following selective activation by small molecule agonist GSK1016790A. PLoS ONE 2011; 6: e16713.
17. Everaerts W, Zhen X, Ghosh D, et al. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc Natl Acad Sci USA 2010; 107: 19084-9.
18. Mochizuki T, Sokabe T, Araki I, et al. The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem 2009; 284: 21257-64.
19. Everaerts W, Vriens J, Owsianik G, et al. Functional characterization of transient receptor potential channels in mouse urothelial cells. Am J Physiol Renal Physiol 2010; 298: F692-701.
20. Aizawa N, Igawa Y, Andersson KE, et al. Effects of intravesical instillation of ATP on rat bladder primary afferent activity and its relationship with capsaicin-sensitivity. Neurourol Urodyn 2011; 30: 163-8.
21. Thorneloe KS, Sulpizio AC, Lin Z, et al. N-((1S)-1-{[4-((2S)-2-{[(2,4- dichlorophenyl)sulfonyl]amino}-3-hydroxypropa noyl)-1-piperazinyl]carbonyl}-3- methylbutyl)-1-benzothiophene-2-carboxamid e (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I. J Pharmacol Exp Ther 2008; 326: 432-42.
22. Aizawa N, Igawa Y, Nishizawa O, et al. Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment. Eur Urol 2011; 59: 264-71.
23. Aizawa N, Igawa Y, Nishizawa O, et al. Effects of CL316,243, a beta 3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 2010; 29: 771-6.
24. Sengupta JN, Gebhart GF,. Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol 1994; 72: 2420-30.
25. Willette RN, Bao W, Nerurkar S, et al. Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2. J Pharmacol Exp Ther 2008; 326: 443-52.
26. Vincent F, Acevedo A, Nguyen MT, et al. Identification and characterization of novel TRPV4 modulators. Biochem Biophys Res Commun 2009; 389: 490-4.
27. Lewis CJ, Surprenant A, Evans RJ,. 2',3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP) - A nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels. Br J Pharmacol 1998; 124: 1463-6.
28. Thomas S, Virginio C, North RA, et al. The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones. J Physiol 1998; 509: 411-7.
29. Virginio C, Robertson G, Surprenant A, et al. Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors. Mol Pharmacol 1998; 53: 969-73.
30. Ralevic V, Burnstock G,. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-92.
31. Lavelle J, Meyers S, Ramage R, et al. Bladder permeability barrier: Recovery from selective injury of surface epithelial cells. Am J Physiol Renal Physiol 2002; 283: F242-53.
32. Matsuura S, Downie JW,. Effect of anesthetics on reflex micturition in the chronic cannula-implanted rat. Neurourol Urodyn 2000; 19: 87-99.